Experimental Hematology
Volume 38, Issue 3 , Pages 202-212, March 2010

Abnormalities of the αβ T-cell receptor repertoire in advanced myelodysplastic syndrome

  • Paulo V. Campregher

      Affiliations

    • Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Wash., USA
    • Drs. Campregher and Srivastava contributed equally to this work.
  • ,
  • Santosh K. Srivastava

      Affiliations

    • Program in Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, Wash., USA
    • Drs. Campregher and Srivastava contributed equally to this work.
  • ,
  • H. Joachim Deeg

      Affiliations

    • Program in Transplantation Biology, Fred Hutchinson Cancer Research Center, Seattle, Wash., USA
    • Department of Medicine, University of Washington, Seattle, Wash., USA
  • ,
  • Harlan S. Robins

      Affiliations

    • Program in Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, Wash., USA
  • ,
  • Edus H. Warren

      Affiliations

    • Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Wash., USA
    • Department of Medicine, University of Washington, Seattle, Wash., USA
    • Corresponding Author InformationOffprint requests to: Edus H. Warren, M.D., Ph.D., Program in Immunology, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, D3-100, P.O. 19024, Seattle, WA 98109-1024

Received 20 August 2009; received in revised form 22 November 2009; accepted 15 December 2009. published online 25 December 2009.

Objective

Analysis of the αβ T-cell receptor (TCR) repertoire in patients with myelodysplastic syndrome (MDS) using the technique of TCR β-chain spectratyping has provided valuable insight into the pathophysiology of cytopenias in a subset of patients with this heterogeneous disorder. TCR β-chain spectratypes are complex data sets, however, and statistical tools for their comprehensive analysis are limited. The objective of the present work was to develop a method to enable quantitative evaluation and global comparison of spectratype data from different individuals and to study the prevalence of TCR β repertoire abnormalities in MDS patients.

Materials and Methods

We developed a robust statistical method based on k-means clustering analysis, and applied this method to analysis of the αβ TCR repertoires in 50 MDS patients and 23 age-matched healthy controls.

Results

Cluster analysis identified a subset of 11 MDS patients with profoundly abnormal αβ TCR repertoires. This group of patients was characterized by advanced disease by International Prognostic Scoring System and World Health Organization criteria, increased expression of the Wilms' tumor-1 oncogene, increased bone marrow myeloblast count, and older age.

Conclusions

We have developed a robust analytic algorithm that enables the comparison of αβ TCR repertoires between individuals and have shown that abnormal αβ TCR repertoire is a feature of a subset of patients with advanced MDS.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-472X(09)00461-5

doi:10.1016/j.exphem.2009.12.004

Experimental Hematology
Volume 38, Issue 3 , Pages 202-212, March 2010